Tetraphase's eravacycline gets FDA fast track status - 1 views
-
Alex Parker on 04 Apr 14The US Food & Drug Administration (FDA) has granted fast track designations for both the intravenous (IV) and oral formulations of Tetraphase Pharmaceuticals' lead antibiotic candidate, eravacycline.